VYOME HOLDINGS, INC. Debt Securities, Available-for-sale, Amortized Cost
VYOME HOLDINGS, INC. (HIND) had Debt Securities, Available-for-sale, Amortized Cost of $8.12 million as of 2018-09-30, per its 10-Q filed 2018-11-02.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2018-11-02
- 2018-09-30: Debt Securities, Available-for-sale, Amortized Cost $8.12M.
- 2018-06-30: Debt Securities, Available-for-sale, Amortized Cost $997.00K.
- 2018-03-31: Debt Securities, Available-for-sale, Amortized Cost $0.00.
- 2017-12-31: Debt Securities, Available-for-sale, Amortized Cost $23.30M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2018-09-30 | $8.12M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $997.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $23.30M 10-Q · filed 2018-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |